Join us at
JPM Healthcare 2025
Book a meeting with us
B. Dusty Majumdar, PhD
CEO
Please complete the form below to schedule a meeting with us at JPM 2025
We are the only company leveraging unbiased spatial analytics and explainable AI to get to the “why” in immunotherapy trials
It is now well understood that complex spatial relationships, the emergence of intermediate cell types and states, as well as communications between cells in tissues are critical components of disease progression and must be major drivers for solutions in precision pathology.
We are the only company that can:
- Identify functionally relevant transition cell states and fusion cell types
- Discover heterogeneous microdomains associated with disease progression and outcomes
- Reveal pathway interactions,signaling networks,potential molecular targets and drugs with microdomain-specific spatial systems pathology